SINOVAC BIOTECH LTD Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost
SINOVAC BIOTECH LTD (SVA) had Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost of $13.05 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost · last filed 2026-06-05
- 2025-12-31: Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost $13.05M.
- 2024-12-31: Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost $38.23M.
- 2023-12-31: Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost $29.33M.
- 2022-12-31: Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost $32.01M.
| Period end | Deferred Tax Liabilities, Deferred Expense, Deferred Policy Acquisition Cost |
|---|---|
| 2025-12-31 | $13.05M 20-F · filed 2026-06-05 |
| 2024-12-31 | $38.23M 20-F · filed 2026-06-05 |
| 2023-12-31 | $29.33M 20-F · filed 2026-04-30 |
| 2022-12-31 | $32.01M 20-F · filed 2026-04-30 |
| 2021-12-31 | $32.15M 20-F · filed 2026-04-30 |